The abstract is read at the publisher; the summary is JClub's.
Next-generation probiotics are best framed as microbial health-promoting products under development, with novelty defined by organism, mechanism, engineering, formulation, or targeted function rather than a fixed category.
- Why it matters: The field needs clearer terminology to reduce ambiguity and align safety, efficacy, intended use, and regulatory pathways across therapeutic and dietary supplement routes.
- What they did: This perspective proposes a unifying framework for NGPs, emphasizing candidates beyond lactic acid bacteria, including commensal microbes from untapped taxa and genetically engineered strains, and discusses safety and regulatory challenges.
- The result: As products become better characterized and their safety and efficacy are established, more specific labels may replace “NGP,” such as the probiotic category or live biotherapeutic products for therapeutic development.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.